The positive safety review from the DSMB enables the trial to move forward as planned, with an estimated completion date in December 2023
Decisions on the marketing authorization for Rystiggo in the European and Japanese markets are expected in Q1 of 2024
Rapid card test kits for iScreen malaria card antigen (Pf/Pv) & iScreen dengue NS1
Urges Innovators to produce quality products that can be deployed at scale
Pfizer is likely to show GSK significant competition
Coverage of CGHS cities has expanded from 25 cities in 2014 to 80 in 2023
The PP-based top and bottom webs are manufactured in a unique coextrusion process
Agilent respectfully disagrees with the PTAB’s opinion of unpatentability in view of prior art previously considered by the USPTO during its primary examination
Cautions against fragmented & siloed efforts in addressing the challenges faced by the world and underlined the need for collaborative efforts to ensure global health security
Nous-209 has been developed using the Nouscom's viral vector platform
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
